We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Artificial Neural Network Improves Prostate Cancer Detection

By HospiMedica International staff writers
Posted on 29 Apr 2019
A new artificial intelligence (AI) system identifies and predicts the aggressiveness of prostate cancer (PC) at the same level of accuracy as experienced radiologists.

Developed at the University of California, Los Angeles (UCLA; USA), FocalNet is a convolutional neural network (CNN) that uses an algorithm with more than a million trainable variables. More...
The CNN was trained using multi-parametric MRI (mp-MRI) scans of 417 men with PC prior to robotic-assisted laparoscopic prostatectomy (RALP). In order to learn how to classify the aggressiveness of the tumor using the Gleason score (GS), the results were compared to the actual pathology specimen. They then compared the AI system's results with readings by UCLA radiologists who had more than 10 years of experience.

The results revealed that in the free-response receiver operating characteristics (FROC) analysis for lesion detection, FocalNet showed 89.7% and 87.9% sensitivity for index lesions and clinically significant lesions, respectively. With the comparison to the prospective performance of radiologists using current diagnostic guidelines, FocalNet demonstrated a detection sensitivity for clinically significant lesions (80.5%) comparable to that of radiologists with at least 10 years of experience (83.9%). The study was presented at the IEEE International Symposium on Biomedical Imaging (ISBI), held during April 2019 in Venice (Italy).

“Multi-parametric MRI is considered the best non-invasive imaging modality for diagnosing prostate cancer. However, mp-MRI for PC diagnosis is currently limited by the qualitative or semi-quantitative interpretation criteria, leading to inter-reader variability and a suboptimal ability to assess lesion aggressiveness,” concluded senior author Kyunghyun Sung, of the UCLA department of radiology, and colleagues. “CNNs are a powerful method to automatically learn the discriminative features for various tasks, including cancer detection.”

CNN’s use a cascade of many layers of nonlinear processing units for feature extraction and conversion, with each successive layer using the output from the previous layer as input to form a hierarchical representation.

Related Links:
University of California, Los Angeles


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.